The finding that TCF4 acts as a negative regulator of IL-17C and ZC3H12A in KCs is potentially novel and may be due to the “opposing” effects of epidermal differentiation and inflammatory responses (49). The gene discussed is ZC3H12A; the disease is dry eye syndrome.